These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. Odekon LE; Sato Y; Rifkin DB J Cell Physiol; 1992 Feb; 150(2):258-63. PubMed ID: 1734031 [TBL] [Abstract][Full Text] [Related]
23. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process. Presta M; Rusnati M; Belleri M; Morbidelli L; Ziche M; Ribatti D Cancer Res; 1999 May; 59(10):2417-24. PubMed ID: 10344752 [TBL] [Abstract][Full Text] [Related]
24. Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. Casu B; Guerrini M; Naggi A; Perez M; Torri G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M Biochemistry; 2002 Aug; 41(33):10519-28. PubMed ID: 12173939 [TBL] [Abstract][Full Text] [Related]
25. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Ribatti D; Nico B; Vacca A; Roncali L; Burri PH; Djonov V Anat Rec; 2001 Dec; 264(4):317-24. PubMed ID: 11745087 [TBL] [Abstract][Full Text] [Related]
26. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis. Sandberg T; Casslén B; Gustavsson B; Benraad TJ Biol Reprod; 1998 Oct; 59(4):759-67. PubMed ID: 9746723 [TBL] [Abstract][Full Text] [Related]
27. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Lansink M; Koolwijk P; van Hinsbergh V; Kooistra T Blood; 1998 Aug; 92(3):927-38. PubMed ID: 9680361 [TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic activity of the purine analog 6-thioguanine. Presta M; Belleri M; Vacca A; Ribatti D Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690 [TBL] [Abstract][Full Text] [Related]
38. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704 [TBL] [Abstract][Full Text] [Related]
39. Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells. van Hinsbergh VW; Koolwijk P; Hanemaaijer R EXS; 1997; 79():391-411. PubMed ID: 9002228 [TBL] [Abstract][Full Text] [Related]
40. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells. Peverali FA; Mandriota SJ; Ciana P; Marelli R; Quax P; Rifkin DB; Della Valle G; Mignatti P J Cell Physiol; 1994 Oct; 161(1):1-14. PubMed ID: 7523424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]